Vedanta Biosciences

OverviewSuggest Edit

Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. Vedanta Biosciences’ proprietary approach leverages foundational discoveries in the field of mucosal immunology to generate safe and potent treatments that restore intestinal homeostasis acting via mechanisms that are orthogonal to all existing drug classes. By modulating the microbiome with this class of drugs, we have the opportunity to treat a range of autoimmune and inflammatory diseases in potentially new ways and impact the lives of patients.
TypePrivate
Founded2010
HQCambridge, US
Websitevedantabio.com

Recent NewsAll News

Latest Updates

Employees (est.) (Oct 2020)85(+4%)
Cybersecurity ratingAMore

Key People/Management at Vedanta Biosciences

Bernat Olle

Bernat Olle

Chief Executive Officer & Director
Chris Viehbacher

Chris Viehbacher

Chairman of the Board
Ben Shapiro

Ben Shapiro

Director
Dan Couto

Dan Couto

Chief Operating Officer
John Lamattina

John Lamattina

Director
Sue Dillon

Sue Dillon

Director
Show more

Vedanta Biosciences Office Locations

Vedanta Biosciences has an office in Cambridge
Cambridge, US (HQ)
19 Blackstone St
Show all (1)

Vedanta Biosciences Financials and Metrics

Summary Metrics

Vedanta Biosciences's latest funding round in September 2019 was reported to be $16.6 m. In total, Vedanta Biosciences has raised $117.5 m
Show all financial metrics

Vedanta Biosciences Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Vedanta Biosciences Online and Social Media Presence

Embed Graph

Vedanta Biosciences News and Updates

Vedanta Biosciences raises $16.6 mln

Vedanta Biosciences said Sept. 23 that it raised $16.6 million in Series C-2 financing. Participants include QUAD Investment Management, SV Investment Corp, Shinhan Investment-Private Equity, Shinhan Capital-Yeollim Partners, Partners Investment Co Ltd, FC Capital, and SymBiosis LLC, who joined the …

Vedanta Biosciences Frequently Asked Questions

  • When was Vedanta Biosciences founded?

    Vedanta Biosciences was founded in 2010.

  • Who are Vedanta Biosciences key executives?

    Vedanta Biosciences's key executives are Bernat Olle, Chris Viehbacher and Ben Shapiro.

  • How many employees does Vedanta Biosciences have?

    Vedanta Biosciences has 85 employees.

  • Who are Vedanta Biosciences competitors?

    Competitors of Vedanta Biosciences include PanTheryx, Morphic Therapeutic and Valneva.

  • Where is Vedanta Biosciences headquarters?

    Vedanta Biosciences headquarters is located at 19 Blackstone St, Cambridge.

  • Where are Vedanta Biosciences offices?

    Vedanta Biosciences has an office in Cambridge.

  • How many offices does Vedanta Biosciences have?

    Vedanta Biosciences has 1 office.